Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Gains from Sales and Divestitures (2017 - 2025)

Historic Gains from Sales and Divestitures for Myomo (MYO) over the last 9 years, with Q3 2025 value amounting to $756001.0.

  • Myomo's Gains from Sales and Divestitures fell 2287.07% to $756001.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $756001.0, marking a year-over-year decrease of 2287.07%. This contributed to the annual value of $1.0 million for FY2024, which is 19586.84% up from last year.
  • According to the latest figures from Q3 2025, Myomo's Gains from Sales and Divestitures is $756001.0, which was down 2287.07% from $644149.0 recorded in Q2 2025.
  • Over the past 5 years, Myomo's Gains from Sales and Divestitures peaked at $1.0 million during Q4 2024, and registered a low of $20.0 during Q2 2021.
  • Its 5-year average for Gains from Sales and Divestitures is $297235.4, with a median of $153357.0 in 2021.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first plummeted by 9989.71% in 2021, then soared by 66625000.0% in 2022.
  • Myomo's Gains from Sales and Divestitures (Quarter) stood at $153357.0 in 2021, then fell by 10.45% to $137332.0 in 2022, then skyrocketed by 147.14% to $339409.0 in 2023, then skyrocketed by 195.87% to $1.0 million in 2024, then fell by 24.72% to $756001.0 in 2025.
  • Its Gains from Sales and Divestitures stands at $756001.0 for Q3 2025, versus $644149.0 for Q2 2025 and $59031.0 for Q1 2025.